Comments
Loading...

Navidea Biopharmaceutical

NAVBOTCEM
Logo brought to you by Benzinga Data
$0.0779
At close: Oct 5, 10:44 AM EDT
$0.0794
0.001501.93%
After Hours: Oct 5, 9:26 AM EDT

Navidea Biopharmaceutical (OTC:NAVB) Stock, Earnings Estimates, EPS, And Revenue

Navidea Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
$610.00

Analyze the earnings history of Navidea Biopharmaceutical using advanced sorting and filters.

Data brought to you by Benzinga APIs

Navidea Biopharmaceutical (NAVB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32021-11-10$-0.08$-0.1127.3 %
Q22021-08-11$-0.09$-0.08-12.5 %
Q12021-05-11$-0.12$-0.08-50.0 %
Q42021-03-24$-0.11$-0.128.33 %

Navidea Biopharmaceutical (NAVB) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q42021-03-24$219.25K$600.00K-63.5 %
Q32020-11-12$268.39K$150.00K78.9 %
Q22020-08-13$271.10K$156.00K73.8 %

FAQ

Q

When is Navidea Biopharmaceutical (OTCEM:NAVB) reporting earnings?

A

Navidea Biopharmaceutical (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Navidea Biopharmaceutical (OTCEM:NAVB)?

A

Navidea Biopharmaceutical (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual EPS was $-0.02, which missed the estimate of $0.00.

Q

What were Navidea Biopharmaceutical’s (OTCEM:NAVB) revenues?

A

Navidea Biopharmaceutical (NAVB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2023 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.